International Journal Of Clinical Pharmacology And Medical Sciences • pp. 1-11
PHARMACOGENOMICS AND ITS ROLE IN PERSONALIZED MEDICINE DEVELOPMENT
Abstract
Pharmacogenomics has emerged as an important field in modern clinical pharmacology, focusing on the
relationship between genetic variations and individual responses to medications. It plays a significant role in
developing personalized medicine by helping healthcare professionals understand how genetic differences influence
drug metabolism, therapeutic effectiveness, treatment outcomes, and adverse drug reactions. Traditional medical
treatment generally follows standardized approaches, in which patients with similar conditions may receive
identical medications and dosages. However, individuals may respond differently to the same treatment because of
variations in their genetic makeup, biological characteristics, and metabolic processes. Pharmacogenomics
provides opportunities to improve treatment selection by identifying genetic factors that influence medication
responses and support individualized therapeutic decisions. Recent developments in genomic technologies,
molecular diagnostics, and clinical genetic testing have strengthened the application of pharmacogenomics in
healthcare. This research examines the role of pharmacogenomics in personalized medicine development, explores
its contribution to drug selection and dosage optimization, and evaluates its potential to improve patient safety and
therapeutic outcomes. The study adopts a qualitative research approach based on a review of recent scientific
literature and published research. The findings highlight that pharmacogenomics can contribute to more effective
treatment strategies, reduce preventable medication-related complications, and support evidence-based clinical
decision-making. However, challenges involving testing costs, clinical implementation, professional education,
ethical concerns, and genetic data privacy remain important considerations. The study concludes that integrating
pharmacogenomics into routine clinical practice can strengthen personalized healthcare and contribute to the
development of safer, more effective, and patient-centered medical treatments.
Record
- Identifier
- https://doi-services.com/1141/230
- Published
- 2026-03-08
- Version
- 1